If you are using a Mozilla® Firefox® browser, Firefox has ended support for Java in March 2017. CareLink® Personal software uses Java plugins to upload data from Medtronic supported medical devices, such as the insulin pumps. Please click here for more information, or contact Customer Support if you have questions.



940M13758-016 20170306

©2017 Medtronic MiniMed, Inc. All rights reserved.

Life with MiniMed 670G System: Perspective of a Busy Teenager

Life with MiniMed 670G System: Perspective of a Busy Teenager

When fifteen-year-old Nikhita wakes up knowing her glucose is stable and will stay in range, she owns the day. Diagnosed with type 1 diabetes at the age of five, the MiniMed 670G system has given Nikhita increased confidence, and reinforced her motivation and determination to continue to achieve more.

I started using the MiniMed 670G system October of my freshman year of high school, and it’s helped me immensely. Before starting the new system, I felt limited in what I could do. I felt like I wasn’t living a “normal” life. The MiniMed 670G system gained my trust, and I feel so much more involved in everything I do. I have more freedom with my diabetes than I could’ve imagined.

Improving Overall Health

The biggest impact the MiniMed 670G system has had on my life is keeping me in range throughout the night and ensuring I wake up with good numbers. I’m able to start every day fresh, and no longer worry about having to bring my number back into range. I’ve had very few night time lows since I started on the new system, which allows me to get a full night’s rest and spend more time and effort doing activities I enjoy. Also, as a young woman, the MiniMed 670G system really helps keep my BG levels stable throughout the month when my hormones are fluctuating, or when I have a cold.

Participating in Competitive Sports

Whether it is playing tennis or going to speech tournaments, I can put my all into whatever I’m doing without having to constantly think about my numbers. Tennis is one of my greatest passions. Prior to the MiniMed 670G system, my BG would drop drastically while playing, and I’d sit out until my numbers were back in range. I’m now the captain of my varsity tennis team and can play an entire tennis game in range, both of which would not have been possible without the MiniMed 670G system.

Strengthening Personal Relationships

Managing my diabetes used to be my biggest stressor because it took up so much of my time and affected everything I did. The MiniMed 670G system has made me a lot more independent, which takes a lot of stress off my parents. I have more time to spend with my family and friends, and don’t limit myself because of my diabetes. My family is from India so we eat a lot of Indian food, which has a lot of carbohydrates. I’m now able to eat my favorite Indian foods without worrying as much about my BG. The system has my back, and because of that, I’ve developed and grown new relationships, and can participate in family traditions.

I see diabetes and the MiniMed 670G system as a part of me, and have grown as an individual because of it. To other teenagers with diabetes, remember you’re stronger because of it.

Important Safety Information

The Medtronic MiniMed 670G system requires a prescription and is intended for continuous delivery of basal insulin (at user selectable rates) and administration of insulin boluses (in user selectable amounts) for the management of Type 1 diabetes mellitus in persons, fourteen years of age and older, requiring insulin as well as for the continuous monitoring and trending of glucose levels in the fluid under the skin. The MiniMed 670G System includes SmartGuard technology, which can be programmed to automatically adjust delivery of basal insulin based on Continuous Glucose Monitor sensor glucose values, and can suspend delivery of insulin when the sensor glucose value falls below or is predicted to fall below predefined threshold values.

The Guardian Sensor (3) is not intended to be used directly for making therapy adjustments, but rather to provide an indication of when a finger stick may be required. All therapy adjustments should be based on measurements obtained using a home glucose monitor and not on values provided by the Guardian Sensor (3).

WARNING: Medtronic performed an evaluation of the MiniMed 670G system and determined that it may not be safe for use in children under the age of 7 because of the way that the system is designed and the daily insulin requirements. Therefore this device should not be used in anyone under the age of 7 years old. This device should also not be used in patients who require less than a total daily insulin dose of 8 units per day because the device requires a minimum of 8 units per day to operate safely.

Pump therapy is not recommended for people whose vision or hearing does not allow recognition of pump signals and alarms. Do not use the serter on products other than the Enlite sensor or Guardian Sensor (3). Medtronic cannot guarantee the safety or efficacy of this product if used with other products. The reservoir is contraindicated for the infusion of blood or blood products.

Infusion sets are indicated for subcutaneous use only and not for intravenous (IV) infusion or the infusion of blood or blood products. Insulin pump therapy is not recommended for those who are unwilling to perform at least four blood glucose tests per day. As insulin pumps use rapid acting insulin only, BG testing is required to help identify rapid glycemic deterioration due to insulin infusion occlusion, infusion site problems, insulin stability issues, user error, or a combination of these. Pump therapy is not recommended for people who are unwilling or unable to maintain contact with their healthcare professional.

The safety of the 670G system has not been studied in people with impaired kidney function. Please let your healthcare professional know if you have kidney disease so you and your healthcare professional can determine if the potential benefits of using the system outweigh the risks. The safety of the 670G system has not been studied in pregnant women, people with type 2 diabetes, or in people using other anti-hyperglycemic therapies apart from insulin. Please let your healthcare professional know if any of these conditions apply to you so you and your healthcare professional can determine if the potential benefits of using the system outweigh the risks.

 

For complete safety information, please consult the appropriate User Guide.

Tags: , , , , , ,

Post A Comment

Your email address will not be published. Required fields are marked *